Compagnie Lombard Odier SCmA - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,000
-37.5%
1,1000.0%0.00%
Q3 2021$8,000
-20.0%
1,1000.0%0.00%
Q2 2021$10,0000.0%1,1000.0%0.00%
Q1 2021$10,0001,1000.00%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2017$16,000
+23.1%
2,0000.0%0.00%
Q1 2017$13,000
-7.1%
2,0000.0%0.00%
Q4 2016$14,000
-26.3%
2,0000.0%0.00%
-100.0%
Q3 2016$19,000
+5.6%
2,0000.0%0.00%0.0%
Q2 2016$18,000
-52.6%
2,000
-54.5%
0.00%0.0%
Q1 2016$38,000
+100.0%
4,400
+51.7%
0.00%0.0%
Q4 2015$19,0002,9000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders